Abrahim Al-Mamgani

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Brachytherapy or stereotactic body radiotherapy boost for early-stage oropharyngeal cancer: comparable outcomes of two different approaches
    Abrahim Al-Mamgani
    Departments of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands Electronic address
    Oral Oncol 49:1018-24. 2013
  2. doi Radiotherapy for T1-2N0 glottic cancer: a multivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients
    A Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Clin Otolaryngol 38:306-12. 2013
  3. doi Node-positive hypopharyngeal cancer treated by (chemo)radiotherapy: impact of up-front neck dissection on outcome, toxicity, and quality of life
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Head Neck 35:1278-86. 2013
  4. doi A prospective evaluation of patient-reported quality-of-life after (chemo)radiation for oropharyngeal cancer: which patients are at risk of significant quality-of-life deterioration?
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasumus MC Danield de Hoed Cancer Center, Rotterdam, The Netherlands
    Radiother Oncol 106:359-63. 2013
  5. doi Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis
    Abrahim Al-Mamgani
    Department of Radiation Oncology Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Technol Cancer Res Treat 12:123-30. 2013
  6. ncbi Unilateral neck irradiation for well-lateralized oropharyngeal cancer
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Radiother Oncol 106:69-73. 2013
  7. doi The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Laryngoscope 123:386-93. 2013
  8. pmc Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands
    Eur Arch Otorhinolaryngol 270:293-9. 2013
  9. ncbi Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus Medical Center Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 84:189-95. 2012
  10. ncbi Highly-conformal intensity-modulated radiotherapy reduced toxicity without jeopardizing outcome in patients with paranasal sinus cancer treated by surgery and radiotherapy or (chemo)radiation
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Oral Oncol 48:905-11. 2012

Collaborators

Detail Information

Publications44

  1. ncbi Brachytherapy or stereotactic body radiotherapy boost for early-stage oropharyngeal cancer: comparable outcomes of two different approaches
    Abrahim Al-Mamgani
    Departments of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands Electronic address
    Oral Oncol 49:1018-24. 2013
    ..To compare outcome, toxicity and QoL of two boost modalities for T1-2 oropharyngeal carcinoma (OPC)...
  2. doi Radiotherapy for T1-2N0 glottic cancer: a multivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients
    A Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Clin Otolaryngol 38:306-12. 2013
    ..To evaluate the outcomes of patients with early stage glottic cancer (GC) treated with radiotherapy (RT)...
  3. doi Node-positive hypopharyngeal cancer treated by (chemo)radiotherapy: impact of up-front neck dissection on outcome, toxicity, and quality of life
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Head Neck 35:1278-86. 2013
    ..To investigate the impact of up-front neck dissection on the outcome of patients with node-positive hypopharyngeal cancer (HPC) treated with (chemo)radiation...
  4. doi A prospective evaluation of patient-reported quality-of-life after (chemo)radiation for oropharyngeal cancer: which patients are at risk of significant quality-of-life deterioration?
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasumus MC Danield de Hoed Cancer Center, Rotterdam, The Netherlands
    Radiother Oncol 106:359-63. 2013
    ..To prospectively investigate the impact of different patients' characteristics on quality-of-life (QoL) after (chemo)radiation for oropharyngeal cancer (OPC)...
  5. doi Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis
    Abrahim Al-Mamgani
    Department of Radiation Oncology Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Technol Cancer Res Treat 12:123-30. 2013
    ..The improved therapeutic ratio achieved by the use of IMRT would allow dose escalation of radiotherapy to further improve outcomes of patients with OPC...
  6. ncbi Unilateral neck irradiation for well-lateralized oropharyngeal cancer
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Radiother Oncol 106:69-73. 2013
    ..To investigate the impact of unilateral neck irradiation (UNI) of well-lateralized oropharyngeal cancer (OPC) on outcome and toxicity...
  7. doi The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Laryngoscope 123:386-93. 2013
    ..To investigate the impact of treatment modality and radiation technique on oncologic outcomes and toxicity of patients with locally advanced oropharyngeal cancer (OPC)...
  8. pmc Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands
    Eur Arch Otorhinolaryngol 270:293-9. 2013
    ..Because of the improvement in therapeutic ratio achieved by using IMRT, this highly conformal radiation technique should be the standard of care in patients with SNUC...
  9. ncbi Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus Medical Center Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 84:189-95. 2012
    ..To assess the outcomes, toxicity, and quality of life (QOL) of patients with primary parotid carcinoma treated with surgery and postoperative radiotherapy at the Daniel den Hoed Cancer Center...
  10. ncbi Highly-conformal intensity-modulated radiotherapy reduced toxicity without jeopardizing outcome in patients with paranasal sinus cancer treated by surgery and radiotherapy or (chemo)radiation
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Oral Oncol 48:905-11. 2012
    ..To report oncologic outcomes of patients with paranasal sinus cancer (PNSC) treated by surgery and radiotherapy or (chemo)radiation and to investigate the impact of improving the radiation technique on outcomes and toxicity...
  11. doi Toxicity, quality of life, and functional outcomes of 176 hypopharyngeal cancer patients treated by (chemo)radiation: the impact of treatment modality and radiation technique
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Laryngoscope 122:1789-95. 2012
    ..The main goal of the current study was to comprehensively address the impact of chemoradiation and radiation techniques on toxicity, quality of life (QoL), and functional outcome...
  12. doi A single-institutional experience of 15 years of treating T3 laryngeal cancer with primary radiotherapy, with or without chemotherapy
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 83:1000-6. 2012
    ....
  13. doi Stereotactic body radiotherapy: a promising treatment option for the boost of oropharyngeal cancers not suitable for brachytherapy: a single-institutional experience
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Groene Hilledijk, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 82:1494-500. 2012
    ....
  14. ncbi Adenoid cystic carcinoma of parotid gland treated with surgery and radiotherapy: long-term outcomes, QoL assessment and review of the literature
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Oral Oncol 48:278-83. 2012
    ..Because effective treatment strategies for this problem are lacking, prospective trials are needed to determine the role of adjuvant systemic or targeted therapy in patients at high risk of DM...
  15. doi Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus Medical Center Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 73:685-91. 2009
    ....
  16. doi Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment
    Abrahim Al-Mamgani
    Erasmus Medical Center Daniel den Hoed Cancer Center, Department of Radiation Oncology, Rotterdam, The Netherlands
    Acta Oncol 48:562-70. 2009
    ..A prospective study of the efficacy and toxicity profile of patients with squamous cell carcinoma of the head and neck (HNSCC) without curative treatment options treated consistently with hypofractionated radiotherapy schedule...
  17. doi Dose escalation and quality of life in patients with localized prostate cancer treated with radiotherapy: long-term results of the Dutch randomized dose-escalation trial (CKTO 96-10 trial)
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 79:1004-12. 2011
    ..To assess the impact of dose escalation of radiotherapy on quality of life (QoL) in prostate cancer patients...
  18. doi Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial
    Abrahim Al-Mamgani
    Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Radiother Oncol 96:13-8. 2010
    ..To investigate the effect of dose escalation within prognostic risk groups in prostate cancer...
  19. ncbi Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer
    Abrahim Al-Mamgani
    Erasmus Medical Centre Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 72:980-8. 2008
    ..To update the analysis of the Dutch dose-escalation trial of radiotherapy for prostate cancer...
  20. ncbi Cardiac metastases
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Groene Hilledijk 301, Rotterdam, The Netherlands
    Int J Clin Oncol 13:369-72. 2008
    ..1% vs 3.8%; Kruskal-Wallis rank test; P = 0.039). Special attention was given to the role of radiotherapy in the management of cardiac metastases...
  21. doi Controversies in the treatment of high-risk prostate cancer--what is the optimal combination of hormonal therapy and radiotherapy: a review of literature
    Abrahim Al-Mamgani
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Prostate 70:701-9. 2010
    ..Furthermore, the issue of the optimal duration and timing of hormonal therapy are not well crystallized...
  22. ncbi Results of fiberoptic endoscopic evaluation of swallowing vs. radiation dose in the swallowing muscles after radiotherapy of cancer in the oropharynx
    David N Teguh
    Department of Radiation Oncology, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Radiother Oncol 89:57-63. 2008
    ..This paper assesses for oropharyngeal cancer (OPC) the relationship between the dose received by the swallowing structures, and the findings of a fiberoptic endoscopic evaluation of the swallowing process (FEES)...
  23. ncbi Intensity-modulated radiotherapy followed by a brachytherapy boost for oropharyngeal cancer
    Abrahim Al-Mamgani
    Departments of Radiation Oncology, Erasmus Medical Center Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Head Neck 35:1689-97. 2013
    ..The purpose of this study was to reduce the incidence of radiation-induced toxicity in patients with early-stage oropharyngeal cancer, using highly conformal radiation techniques...
  24. ncbi Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer
    Stephanie T H Peeters
    Department of Radiation Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 64:1151-61. 2006
    ..To identify dosimetric parameters derived from anorectal, rectal, and anal wall dose distributions that correlate with different late gastrointestinal (GI) complications after three-dimensional conformal radiotherapy for prostate cancer...
  25. doi Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs. 78 Gy): relationships with local dose, acute effects, and baseline characteristics
    Wilma D Heemsbergen
    Department of Radiation Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 78:19-25. 2010
    ..To investigate the relationship between late urinary obstruction and the details of the dose distribution of irradiated prostate cancer patients, taking into account their baseline symptoms and acute complaints...
  26. doi Relating dose outside the prostate with freedom from failure in the Dutch trial 68 Gy vs. 78 Gy
    Marnix G Witte
    Department of Radiation Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 77:131-8. 2010
    ..For prostate cancer patients at risk for subclinical spread of the disease, we investigated whether incidental dose outside the target was associated with tumor control...
  27. ncbi Fully automated volumetric modulated arc therapy plan generation for prostate cancer patients
    Peter W J Voet
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands Electronic address
    Int J Radiat Oncol Biol Phys 88:1175-9. 2014
    ..To develop and evaluate fully automated volumetric modulated arc therapy (VMAT) treatment planning for prostate cancer patients, avoiding manual trial-and-error tweaking of plan parameters by dosimetrists...
  28. doi Three-dimensional dose addition of external beam radiotherapy and brachytherapy for oropharyngeal patients using nonrigid registration
    Eliana M Vasquez Osorio
    Department of Radiation Oncology, Daniel den Hoed Cancer Center, Erasmus Medical Center, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 80:1268-77. 2011
    ..To develop and evaluate a method for adding dose distributions of combined external beam radiotherapy (EBRT) and brachytherapy (BT) for oropharyngeal patients...
  29. doi Radiotherapy with rectangular fields is associated with fewer clinical failures than conformal fields in the high-risk prostate cancer subgroup: results from a randomized trial
    Wilma D Heemsbergen
    Department of Radiation Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Radiother Oncol 107:134-9. 2013
    ..Nowadays, tight margins reduce dose to periprostatic areas compared to earlier techniques. We investigated whether rectangular fields were associated with fewer failures compared to conformal fields (with lower extraprostatic dose)...
  30. doi IMRT for image-guided single vocal cord irradiation
    Sarah O S Osman
    Department of Radiation Oncology, Erasmus Medical Center Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 82:989-97. 2012
    ..In the present study, we compared the dose coverage to the affected vocal cord and the dose delivered to the organs at risk using conventional, intensity-modulated radiotherapy (IMRT) coplanar, and IMRT non-coplanar techniques...
  31. ncbi Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx
    David N Teguh
    Department of Radiation Oncology, Erasmus Medical Center Daniel den Hoed, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 72:1119-27. 2008
    ..To assess the relationship for oropharyngeal (OP) cancer and nasopharyngeal (NP) cancer between the dose received by the swallowing structures and the dysphagia related quality of life (QoL)...
  32. pmc Early and long-term morbidity after total laryngopharyngectomy
    Stijn Keereweer
    Department of Head and Neck Surgery, Erasmus University Medical Center, Daniel den Hoed Cancer Center, 301 Groene Hilledijk, 3075 EA, Rotterdam, The Netherlands
    Eur Arch Otorhinolaryngol 267:1437-44. 2010
    ..Complete oral intake was achieved in 97%, and speech rehabilitation in 95%. These procedures are associated with significant morbidity, high complication rates, lengthy rehabilitation, but a good long-term quality of life...
  33. ncbi Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer
    Stephanie T H Peeters
    Department of Radiation Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 63:1142-52. 2005
    ....
  34. pmc Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only
    Jan J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER Enschede, The Netherlands
    Obstet Gynecol Int 2011:962518. 2011
    ..Conclusion. Endometrial carcinoma stage IIIA with involvement of the adnexa or serosa showed to have a comparable disease-specific survival. Locoregional control was worse for serosa involvement compared to adnexa...
  35. doi Local control in advanced cancer of the nasopharynx: is a boost dose by endocavitary brachytherapy of prognostic significance?
    Peter C Levendag
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Brachytherapy 12:84-9. 2013
    ..To analyze whether local tumor control in advanced nasopharyngeal cancer (NPC) can be optimized by boosting the primary dose by endocavitary brachytherapy (EBT)...
  36. doi The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor
    Jan J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Gynecol Oncol 117:32-6. 2010
    ..The aim of this study was to look at the impact of the number of sites with tumour involvement on outcome for patients with stage IIIA endometrioid-type endometrial carcinoma...
  37. pmc Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life
    Stijn Keereweer
    Department of Otorhinolaryngology Head and Neck Surgery, Erasmus University Medical Center, P O Box 2040, 3000 CA, Rotterdam, The Netherlands
    Eur Arch Otorhinolaryngol 269:939-46. 2012
    ..However, significant acute and long-term toxic effects occur, and organ preservation appears not necessarily equivalent to preservation of function and better QOL...
  38. doi Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival
    Wilma D Heemsbergen
    Department of Radiation Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Electronic address
    Radiother Oncol 110:104-9. 2014
    ..Nowadays, advanced irradiation techniques make it possible to escalate safely the dose in prostate cancer. We studied the effect of a higher dose on tumor control in a randomized trial with a median follow-up of 110 months...
  39. doi Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors
    Aafke C Kraan
    Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands Electronic address
    Int J Radiat Oncol Biol Phys 87:888-96. 2013
    ..We quantified these factors and investigated treatment fidelity, that is, robustness, as influenced by adaptive planning and by applying more beam directions...
  40. doi Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration
    Eliana M Vasquez Osorio
    Department of Radiation Oncology, Daniel den Hoed Cancer Center, Erasmus Medical Center, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 70:875-82. 2008
    ..To quantify the anatomic changes caused by external beam radiotherapy in head-and-neck cancer patients in full three dimensions and to relate the local anatomic changes to the planned mean dose...
  41. doi Clinical validation of atlas-based auto-segmentation of multiple target volumes and normal tissue (swallowing/mastication) structures in the head and neck
    David N Teguh
    Department of Radiation Oncology, Erasmus Medical Center, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 81:950-7. 2011
    ..To validate and clinically evaluate autocontouring using atlas-based autosegmentation (ABAS) of computed tomography images...
  42. ncbi Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for recurrent laryngeal cancer
    Aniel Sewnaik
    Department of Otolaryngology Head and Neck Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    Ann Otol Rhinol Laryngol 115:419-24. 2006
    ..We performed a retrospective study to analyze the functional and oncological results of supracricoid laryngectomy with CHEP...
  43. doi Combined therapy for thyroid squamous cell carcinoma
    Filip Yves F L De Vos
    Department of Internal Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Head Neck 34:131-4. 2012
    ..CONCLUSIONS.: Our patient now has a recurrence-free survival of >20 months, longer than the mean survival described in the literature...
  44. ncbi Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial
    Carien L Creutzberg
    Department of Radiation Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    J Clin Oncol 22:1234-41. 2004
    ..Stage IC, grade 3 patients were not eligible for the randomized Postoperative Radiation Therapy in Endometrial Carcinoma (PORTEC) trial, but were registered and received postoperative radiotherapy...